Contemporary Detection Of 4-Demeth-Oxydaunorubicin And Its Metabolites 13-Dihydro-4-Demethoxydaunorubicin And4-Demethoxydaunorubicinone By Reverse Phase High-Performance Liquid Chromatography

References

• Hackmann , C. 1952 . Experimental investigation on the action of Actinomycin C (HBF 386) in malignant tumors . Zeitscnr. Krebsforshc. , 58 : 607
   PubMedGoogle Scholar
• Di Marco , A. , Gaetani , M. , Dorigotti , L. , Soldati , M. , Bellini , O. and Daunomycin . 1964 . a new antibiotic with antitumor activity . Cancer Chemother. Rep. , 38 : 31
   PubMedGoogle Scholar
• Karter , S. K. 1974 . Adriamycin a review . J. Natl. Cancer Inst. , 55 : 1265
   Google Scholar
• Gole , R. P. and Cline , M. J. 1977 . High remission induction rate In acute myeloid leukemia . Lancet , 1 : 497
   PubMedGoogle Scholar
• Weiss , R. B. and Bruno , S. 1981 . Daunorubicin treatment of adult solid tumors . Cancer Treat. Rep. , 65 ( 4 ) : 25
   PubMedGoogle Scholar
• De Vita , V. T. Jr. , Hellman , S. and Rosenberg , S. A. Cancer - Principles and practice of oncology , 1982 Philadelphia : J. B. Lippincott Co. .
   Google Scholar
• Lenaz , L. and Page , J. A. 1976 . Cardiotoxicity of adriamycin and related anthracy-clines . Cancer Treat. Rev. , 3 : 111
   PubMed Web of Science ®Google Scholar
• Unverferth , D. V. , Magorien , R. D. , Leier , C. V. and Balcerzac , S. P. 1982 . Ooxorubicin cardiotoxicity . Cancer. Treat. Rev. , 9 : 146
   Google Scholar
• Di Marco , A. , Casazza , A. M. , Uasdia , T. , Giuliani , F. , Lenaz , L. , Neceo , A. and Soranzo , C. 1973 . Cytotoxic antiviral and antitumor activity of some derivatives of daunomycin (NSC 82151) . Cancer Chemother. Rep. , 57 : 269
   PubMedGoogle Scholar
• Arcamone , F. , Penco , S. , Vigevani , A. , Redaelli , S. , Franchi , G. , Di Marco , A. , Casazza , A. M. , Dasida , T. , Formelli , F. , Neceo , A. and Soranzo , C. 1975 . Synthesis and antitumor properties of new glicosydes of daunomycinone and adriamycinone . J. Med. Chetn. , 18 : 703
   PubMed Web of Science ®Google Scholar
• Arcamone , F. , Bernardi , L. , Giardino , P. , Patelli , B. , Di Marco , A. , Casazza , A. M. , Pratesi , G. and Reggiani , P. 1976 . Synthesis and antitumor activity of 4-deme-toxydaunorubicin, 4-demethoxy 7,9 diepi daunorubicin and their β anomers . Cancer Treat. Rep. , 60 : 829
   PubMedGoogle Scholar
• Di Marco , A. , Casazza , A. M. , Giuliani , F. , Pratesi , G. , Arcamone , F. , Bernardi , L. , Franchi , G. , Giardino , P. , Patelli , B. and Penco , S. 1978 . Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-deinethoxy-4′-epiadriamycin . Cancer Treat. Rep. , 62 : 375
   PubMedGoogle Scholar
• Smith , T. H. , Fujiwara , A. N. and Henry , D. W. 1979 . Synthesis of daunorubicin analogues with a novel 9-acyl-substitutes . J. Med. Chem. , 22 : 40
   PubMedGoogle Scholar
• Lu , K. , Savaraj , N. , Kavanagh , R. S. , Benjamin , L. , Feun , M. , Burgess , M. , Bodey , G. and Loo , T. L. 1984 . Clinical pharmacology of 4-demethoxy-daunorubicin (DMDR) . Proc. Am. Soc. Clin. Oncol. , 3 : 38
   Google Scholar
• Bastholt , L. , Ejlertsen , B. and Dalmark , M. 1985 . A phase II trial of oral 4-demetho-xydaunorubicin (DMUR) in patients with measurable advanced carcinoma of the breast . Proc Am. Assoc. Cancer Res. , 26 : 164
   Google Scholar
• Bacha , D. , Steinherz , L. , Dantis , E. , Mondora , A. and Tan , C. 1985 . Phase I study of oral Idarubicin (4DMDR) in children with cancer . Proc. Am. Assoc. Cancer Res. , 26 : 186
   Google Scholar
• Daghestani , A. M. , Zalmen , A. A. , Leyland-Jones , B. , Gee , T. S. , Kempin , S. J. , Mertelsmann , R. , Budman , D. , Schulman , P. , Baratz , R. , Williams , L. , Clarkson , B. D. and Young , C. W. 1985 . Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (Idarubicin) in adult patients with acute leukemia . Cancer Res. , 45 : 1408
   PubMed Web of Science ®Google Scholar
• Powis , G. , Ames , M. M. and Kovach , J. S. 1981 . Dose-dependent pharmacokinetics and cancer chemotherapy. Cancer Chemother . Pharmacol. , 6 : 1
   Google Scholar
• Eksborg , S. 1978 . Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxil metabolites adriamycinol and daunorubicinol . J. Chromatog. , 149 : 225
   PubMed Web of Science ®Google Scholar
• Eksborg , S. , Ehrsson , H. , Andersson , B. and Bevan , M. 1978 . Liquid Chromatographie detection of daunorubicin and daunorubicinol in plasma from leukemic patients . J. Chromatog. , 153 : 211
   PubMedGoogle Scholar
• Eksborg , S. , Ehrsson , H. and Andersson , B. 1979 . Reversed-phase liquid Chromatographic deyection of plasma levels of adriamycin and adriamycinol . J. Croma-tog. , 164 : 479
   PubMed Web of Science ®Google Scholar
• Moro , E. , Jannuzzo , M. G. , Ranghieri , M. , Stegnjaich , S. and Valzelli , G. 1982 . Detection of 4′epidoxorubicin and its 13-dihydroderivative in human plasma by high performance liquid chromatography with fluorescence detection . J. Chromatog. , 230 : 207
   PubMedGoogle Scholar
• Moro , E. , Bellotti , V. , Jannuzzo , M. G. , Stegnjaich , S. and Valzelli , G. 1983 . High performance liquid chromatographyc method for pharmacokinetic studies of the new anthracyclines 4-demethoxydaunorubicin and its 13-dihydroderivative . J. Chromatog. , 274 : 281
   PubMed Web of Science ®Google Scholar
• Mhatre , R. , Herman , E. , Huidobro , A. and Waravdekar , V. 1971 . The possible relationship between metabolism and cardiac toxicity of daunomycin and related compounds . J. Pharmacol. Exp. Ther. , 178 : 216
   PubMed Web of Science ®Google Scholar
• Herman , E. H. , Mhatre , R. M. and Chadwick , D. P. 1974 . Modification of some of the toxic effects of daunomycin (NSC 82151) by pretreatment with the antineoplastic agent IRCF 159(129943) . Toxicol. Appl. Pharmacol. , 27 : 517
   PubMed Web of Science ®Google Scholar
• Bachur , N. R. 1976 . Cytoplasmic aldo-cheto reductases: a class of drug metabolizing enzymes . Science , 193 : 595
   PubMed Web of Science ®Google Scholar